Amendment on the Bidding Document and Tender Closing/Opening Date Extension(ICB/EPSS6/RDF-R/PH/17/23)
Tender Code: ICB/EPSS6/RDF-R/PH/17/23
Tender Type: ICB
Closed Date: 10/17/2023 2:00pm
Opening Date: 10/17/2023 2:30pm
Product category: pharmaceuticals
Download File: Download
To: All participants of Tender No. ICB/EPSS6/RDF-R/PH/17/23
Sub: Amendment on the Bidding Document and Tender Closing/Opening Date Extension.
Dear Sirs/Madams,
Thank you for your interest for the participation of the above captioned tender.
1.Please be informed that an amendment is made to part 2, Section 6: Statement of requirement under A. Technical specification-General requirement of the bidding document, the following items described in the table below are cancelled from this tender hence, the bidders are required to adjust their bid documents accordingly before the submission due date.
The Lists of Items which are cancelled are:
Item No. | Description | Unit | Quantity |
1 | Amlodipine – 5mg – Tablet | 10×10 | 126,328 |
2 | Amoxicillin – 250 mg/5 ml – Suspension | 100 ml | 2,303,040 |
5 | Azithromycin – 500mg – Tablet | 10×3 | 132,810 |
6 | Benzhexol (Trihexyphenidyl HCL) – 2mg – Tablet | 10×10 | 10,610 |
7 | Benzhexol (Trihexyphenidyl HCL) – 5mg – Tablet | 10×10 | 10,420 |
12 | Ceftriaxone – 1gm with 10ml diluents – Injection | Vial | 7,049,338 |
13 | Cephalexine – 250 mg/5ml – Oral Suspension | 100ml | 182,946 |
17 | Cloxacillin Sodium – 250mg/5ml – Oral Suspension | 100ml | 1,145,357 |
25 | Metronidazole – 125mg/5ml – Oral Suspension | 100ml | 841,722 |
26 | Metronidazole – 250mg – Capsule | 100×10 | 147,712 |
29 | Ondansetrone – 8mg/4ml – Injection | Each | 25,000 |
35 | Sodium Valproate – 500mg – Tablet | 100 | 28,880 |
36 | Sulphamethoxazole + Trimethoprim – (200mg + 40mg)/5ml – Suspension | 100ml | 1,230,006 |
38 | Tinidazole – 500 mg – Tablet | 60×4 | 89,020 |
- The closing and opening date and time of the tender are extended to October 17, 2023; 2:00 PM and 2:30 PM respectively, so the bidders shall again adjust the necessary documents accordingly.
All the other terms, conditions, criteria & requirements will be the same.
Finally we apologize for the inconvenience you may face in advance
With regards
CC
- Deputy Director General/Inbound/
- Pharmaceuticals Procurement Team /RDF/
- Archive
EPSS